Author:
Ghaffari Kazem,Moradi-Hasanabad Amin,Sobhani-Nasab Ali,Javaheri Javad,Ghasemi Ali
Abstract
Exosomes are small membrane vesicles of endocytic origin that are produced by both tumor and normal cells and can be found in physiological fluids like plasma and cell culture supernatants. They include cytokines, growth factors, proteins, lipids, RNAs, and metabolites and are important intercellular communication controllers in several disorders. According to a vast amount of research, exosomes could support or inhibit tumor start and diffusion in a variety of solid and hematological malignancies by paracrine signaling. Exosomes are crucial therapeutic agents for a variety of illnesses, such as cancer and autoimmune diseases. This review discusses the most current and encouraging findings from in vitro and experimental in vivo research, as well as the scant number of ongoing clinical trials, with a focus on the impact of exosomes in the treatment of malignancies. Exosomes have great promise as carriers of medications, antagonists, genes, and other therapeutic materials that can be incorporated into their core in a variety of ways. Exosomes can also alter the metabolism of cancer cells, alter the activity of immunologic effectors, and alter non-coding RNAs, all of which can alter the tumor microenvironment and turn it from a pro-tumor to an anti-tumor milieu. This subject is covered in the current review, which also looks at how exosomes contribute to the onset and progression of hematological malignancies, as well as their importance in diagnosing and treating these conditions.
Subject
Pharmacology (medical),Pharmacology
Reference192 articles.
1. The effect of simultaneous administration of arsenic trioxide and microvesicles derived from human bone marrow mesenchymal stem cells on cell proliferation and apoptosis of acute myeloid leukemia cell line;Abbaszade Dibavar;Artif. Cells, Nanomedicine, Biotechnol.,2018
2. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake;Abels;Cell. Mol. Neurobiol.,2016
3. Controlled drug delivery systems: current status and future directions;Adepu;Molecules,2021
4. Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications;Ahmadi;J. Transl. Med.,2020
5. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells;Al-Nedawi;Nat. Cell Biol.,2008
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献